These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2571949)

  • 1. [The effect of immunoscintigraphy with monoclonal antibodies on assays of hormones and tumor markers. This is not the end of the matter!].
    Janssen JA; Blankestijn PJ; Docter R; Blijenberg BG; Lamberts SW; Krenning EP
    Ned Tijdschr Geneeskd; 1989 Jul; 133(29):1455-8. PubMed ID: 2571949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of immunoscintigraphy using monoclonal antibodies on the analysis of hormones and tumor markers. This is not the end of it!].
    Verheijen RH; Schijf CP
    Ned Tijdschr Geneeskd; 1989 Sep; 133(35):1760. PubMed ID: 2797292
    [No Abstract]   [Full Text] [Related]  

  • 3. [Type II-B multiple endocrine neoplasms. A new sporadic case].
    González-Atienza J; Pérez A; LupónJ ; Ribera E; Sobrino J; Lucaya J
    Med Clin (Barc); 1984 Mar; 82(10):454-6. PubMed ID: 6143865
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypersensitivity to therapeutic murine monoclonal antibodies.
    Kornbrot B; Kobayashi RH; Singer A; Tempero MA; Heiner DC
    Nebr Med J; 1994 Dec; 79(12):393-8. PubMed ID: 7870212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The "false positive" tumor marker in malignant testicular tumor].
    Bussar-Maatz R; Weissbach L; Dahlmann N; Mann K
    Urologe A; 1993 May; 32(3):177-82. PubMed ID: 8511831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated carcinoembryonic antigen (CEA) levels in a patient with no malignancy.
    Shapiro M; Scapa E
    Hepatogastroenterology; 2000; 47(31):163-4. PubMed ID: 10690602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CEA polyclonal antibodies, CEA monoclonal antibodies, tissue polypeptide antigen in the sera of supposedly healthy individuals.
    Pluygers EP; Beauduin MP; Baldewyns PE
    Cancer Detect Prev Suppl; 1987; 1():231-4. PubMed ID: 3480052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human anti-mouse antibodies: pitfalls in tumor marker measurement and strategies for enhanced assay robustness; including results with Elecsys CEA.
    Nussbaum S; Roth HJ
    Anticancer Res; 2000; 20(6D):5249-52. PubMed ID: 11326704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of calcitonin and carcinoembryonic antigen doubling times in medullary thyroid carcinoma.
    Jackson CE; Norum RA; Talpos GB; Feldkamp CS; Tashjian AH
    Henry Ford Hosp Med J; 1987; 35(2-3):120-1. PubMed ID: 2891643
    [No Abstract]   [Full Text] [Related]  

  • 10. Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.
    Väisänen V; Peltola MT; Lilja H; Nurmi M; Pettersson K
    Anal Chem; 2006 Nov; 78(22):7809-15. PubMed ID: 17105175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy.
    Haskell CM; Buchegger F; Schreyer M; Carrel S; Mach JP
    Cancer Res; 1983 Aug; 43(8):3857-64. PubMed ID: 6344991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content.
    Pagé M; Dalifard I; Bertrand G; Bocquillon PG; Daver A
    Anticancer Res; 1986; 6(5):893-6. PubMed ID: 3541780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers in colorectal cancer: diagnostic and therapeutic implications.
    Luk GD; Desai TK; Conteas CN; Moshier JA; Silverman AL
    Gastroenterol Clin North Am; 1988 Dec; 17(4):931-40. PubMed ID: 3068151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the measurement of serum carcinoembryonic antigen (CEA) levels using monoclonal antibody].
    Yoneshima M; Sawabu N; Kidani H; Takemori Y; Toya D; Okai T; Hattori N; Ogino T; Mai M
    Gan No Rinsho; 1985 Aug; 31(10):1311-7. PubMed ID: 4057566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of tumor markers in digestive oncology].
    Ychou M; Rougier P; Bidart JM; Bellet D; Tigaud JM; Bohuon C
    Ann Chir; 1989; 43(7):517-23. PubMed ID: 2694905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas.
    Feil G; Wechsel HW; Nelde HJ; Bichler KH
    Anticancer Res; 1999; 19(4A):2591-7. PubMed ID: 10470200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
    Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
    Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
    Wang YD; Hu Y; Zhang L; Huang J; Sun CY
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.